Serna-Thomé G, Castro-Eguiluz D, Fuchs-Tarlovsky V, Sánchez-López M, Delgado-Olivares L, Coronel-Martínez J, Molina-Trinidad EM, de la Torre M, Cetina-Pérez L

Idioma: Ingles.
Referencias bibliográficas: 41
Paginas: 136-146
Archivo PDF: 100.18 Kb.

RESUMEN

Sin resumen.

REFERENCIAS (EN ESTE ARTÍCULO)

1. Cederholm T, Barazzoni R, Austin P, et al. ESPEN guidelines on definitions and terminology of clinical nutrition. Clin Nutr. 2017;36:49-64.

2. Souba WW. Glutamine and cancer. Ann Surg. 1993;218:715-28.

3. Uscátegui H. Inmunonutrición: enfoque en el paciente quirúrgico* Immunonutrition: approach on surgical patient. Rev Chil Cirugía. 2010;62:87-92.

4. Vidal-Casariego A, Calleja-Fernández A, de Urbina-González JJ, Cano-Rodríguez I, Cordido F, Ballesteros-Pomar MD. Efficacy of glutamine in the prevention of acute radiation enteritis: a randomized controlled trial. J Parenter Enteral Nutr. 2014;38: 205-13.

5. Kucuktulu E, Guner A, Kahraman I, Topbas M, Kucuktulu U. The protective effects of glutamine on radiation-induced diarrhea. Support Care Cancer. 2013;21:1071-5.

6. Martinez-Outschoorn UE, Peiris-Pagés M, Pestell RG, Sotgia F, Lisanti MP. Cancer metabolism: a therapeutic perspective. Nat Rev Clin Oncol. 2017;14:11-31.

7. Calder R. Docosahexaenoic acid. Adv Nutr. 2016;7:1139-41.

8. Jiang WG, Bryce RP, Horrobin DF. Essential fatty acids: molecular and cellular basis of their anti-cancer action and clinical implications. Crit Rev Oncol Hematol. 1998;27:179-209.

9. Bougnoux P. N-3 polyunsaturated fatty acids and cancer. Curr Opin Clin Nutr Metab Care. 1999;2:121-6.

10. Gonzalez MJ, Schemmel RA, Dugan L Jr., Gray JI, Welsch CW. Dietary fish oil inhibits human breast carcinoma growth: a function of increased lipid peroxidation. Lipids. 1993;28:827-32.

11. Gonzalez MJ, Schemmel RA, Gray JI, et al. Effect of dietary fat on growth of MCF-7 and MDA-MB231 human breast carcinomas in athymic nude mice: relationship between carcinoma growth and lipid peroxidation product levels. Carcinogenesis. 1991;12:1231-5.

12. Ells GW, Chisholm KA, Simmons VA, Horrobin DF. Vitamin E blocks the cytotoxic effect of gamma-linolenic acid when administered as late as the time of onset of cell death–insight into the mechanism of fatty acid induced cytotoxicity Cancer Lett. 1996;98:207-11.

13. Begin ME, Ells G, Horrobin DF. Polyunsaturated fatty acid-induced cytotoxicity against tumor cells and its relationship to lipid peroxidation. J Natl Cancer Inst. 1988;80:188-94.

14. Sagar PS, Das UN, Koratkar R, et al. Cytotoxic action of cisunsaturated fatty acids on human cervical carcinoma (HeLa) cells: relationship to free radicals and lipid peroxidation and its modulation by calmodulin antagonists. Cancer Lett. 1992;63: 189-98.

15. Jordan A, Stein J. Effect of an omega-3 fatty acid containing lipid emulsion alone and in combination with 5-fluorouracil (5- FU) on growth of the colon cancer cell line caco-2. Eur J Nutr. 2003;42:324-31.

16. Fearon KC, Von Meyenfeldt MF, Moses AG, et al Effect of a protein and energy dense N-3 fatty acid enriched oral supplement on loss of weight and lean tissue in cancer cachexia: a randomised double blind trial. Gut. 2003;52:1479-86.

17. Das UN, Ramos EJB, Meguid MM. Metabolic alterations during inflammation and its modulation by central actions of omega-3 fatty acids. Curr Opin Clin Nutr Metab Care. 2003;6:413-419.

18. Badjatia N, Satyam A, Singh P, Seth A, Sharma A. Altered antioxidant status and lipid peroxidation in indian patients with urothelial bladder carcinoma. Urol Oncol. 2010;28 360-7.

19. Fuchs-Tarlovsky V. Role of antioxidants in cancer therapy. Nutrition. 2013;29:15-21.

20. Fuchs-Tarlovsky V, Bejarano-Rosales M, Gutierrez Salmean G, et al. Effect of antioxidant supplementation over oxidative stress and quality of life in cervical cancer. Nutr Hosp. 2011; 26:819-26.

21. Fuchs-Tarlovsky V, Rivera MA, Altamirano KA, Lopez-Alvarenga JC, Ceballos-Reyes GM. Antioxidant supplementation has a positive effect on oxidative stress and hematological toxicity during oncology treatment in cervical cancer patients. Support Care Cancer. 2013;21:1359-63.

22. Fuchs-Tarlovsky V, Gutiérrez-Salmeán G, Casillas MA, Bejarano- Rosales M, Reyes GM. Suplementación con antioxidantes no previene nefrotoxicidad por cisplatino en pacientes con cáncer cérvico uterino avanzado. Rev Venez Oncol. 2011;23;21-5.

23. Arends J, Bachmann P, Baracos V, et al. ESPEN guidelines on nutrition in cancer patients. Clin Nutr. 2016;36:11-48.

24. Wang L, Sesso H, Glynn R, et al. Vitamin E and C supplementation and risk of cancer in men: posttrial follow-up in the physicians’ health study II randomized trial. Am J Clin Nutr. 2014; 101:915-23.

25. García-Zepeda SP, García-Villa E, Díaz-Chávez J, Hernández- Pando R, Gariglio P. Resveratrol induces cell death in cervical cancer cells through apoptosis and autophagy. Eur J Cancer Prev. 2013;22:577-84.

26. León-González AJ, Auger C, Schini-Kerth VB. Pro-oxidant activity of polyphenols and its implication on cancer chemoprevention and chemotherapy. Biochem Pharmacol. 2015;98:371-80.

27. Trueba GP. Los flavonoides: antioxidantes o prooxidantes. Rev Cuba Investig Biomed. 2003;22:48-57.

28. ILSI. Scientific concepts of functional foods in Europe. Consensus document. Br J Nutr. 1999;81 Suppl 1:S1-S27.

29. Reig AD, Anesto J. Prebióticos y probióticos, una relación beneficiosa. Rev Cuba Aliment Nutr. 2002;16:63-8.

30. Pérez-Conesa D, López G, Ros G. Principales prebióticos y sus efectos en la alimentación humana. An Vet. 2004;20:5-20.

31. Gibson GR, Scott KP, Rastall RA, et al. Dietary prebiotics: current status and new definition. Food Sci Technol Bull Funct Foods. 2010;7:1-19.

32. Reid G. Probiotics: definition, scope and mechanisms of action. Best Pract Res Clin Gastroenterol. 2016;30:17-25

33. Wang YH, Yao N, Wei KK, et al. The efficacy and safety of probiotics for prevention of chemoradiotherapy-induced diarrhea in people with abdominal and pelvic cancer: a systematic review and meta-analysis. Eur J Clin Nutr. 2016;70:1246-53.

34. Wada M, Nagata S, Saito M, et al. Effects of the enteral administration of Bifidobacterium breve on patients undergoing chemotherapy for pediatric malignancies. Support Care Cancer. 2010;18:751-9.

35. Osterlund P, Ruotsalainen T, Korpela R, et al. Lactobacillus supplementation for diarrhoea related to chemotherapy of colorectal cancer: a randomised study. Br J Cancer. 2007; 97:1028-34.

36. Urbancsek H, Kazar T, Mezes I, Neumann K. Results of a doubleblind, randomized study to evaluate the efficacy and safety of antibiophilus in patients with radiation-induced diarrhoea. Eur J Gastroenterol Hepatol. 2001;13:391-6.

37. Giralt J, Regadera JP, Verges R, et al. Effects of probiotic Lactobacillus casei DN-114 001 in prevention of radiation-induced diarrhea: results from multicenter, randomized, placebo-controlled nutritional trial. Int J Radiat Oncol Biol Phys. 2008;71:1213-9.

38. Delia P, Sansotta G, Donato V, et al. Prevention of radiation-induced diarrhea with the use of VSL#3, a new high-potency probiotic preparation [10]. Am J Gastroenterol. 2002;97:2150-2.

39. Delia P, Sansotta G, Donato V, et al. Use of probiotics for prevention of radiation-induced diarrhea. World J Gastroenterol. 2007;13:912-5.

40. Chitapanarux I, Chitapanarux T, Traisathit P, Kudumpee S, Tharavichitkul E, Lorvidhaya V. Randomized controlled trial of live Lactobacillus acidophilus plus Bifidobacterium bifidum in prophylaxis of diarrhea during radiotherapy in cervical cancer patients. Radiat Oncol. 2010;5:31.

41. Mego M, Holec V, Drgona L, Hainova K, Ciernikova S, Zajac V. Probiotic bacteria in cancer patients undergoing chemotherapy and radiation therapy. Complement Ther Med. 2013;21: 712-23.